Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Determination of whether accelerated radiotherapy or stereotactic APBI is a feasible and safe alternative to whole breast radiotherapy.
Frederick M. Dirbas
United States: Food and Drug Administration
|Stanford University School of Medicine||Stanford, California 94305-5317|